American College of Clinical Pharmacy   Report issue

Foundation Phase 1 Phase 2 Phase 4
Founded: Lenexa KS United States (1942)

Organization Overview

First Clinical Trial
2004
NCT00361283
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

American College of Clinical Pharmacy

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma, Exercise-Induced (Phase 4)

Atherosclerosis (Phase 4)

Bronchial Spasm (Phase 4)

Glomerulonephritis, Membranous (Phase 1)

Heart Failure (Phase 4)

Inflammation (Phase 4)

Nephrosis (Phase 1)

Nephrotic Syndrome (Phase 1)

Syndrome (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 8
  • # of Trial APIs: 12